Category Archives: genomics

Is Helix DTC Genomics 2.0?

Just a few years ago there were several prominent consumer genomics companies, including 23andMe, Decode, and Navigenics. Due to low uptake, problems with industry image and quality, and regulatory woes the larger players have one by one discontinued pursuing purely … Continue reading






Posted in DTC Genetic Testing, genomics, personalized medicine | Comments Off on Is Helix DTC Genomics 2.0?

Continuing Fallout from the Decision to Overturn Myriad’s Patents

I follow the genetic testing field and have watched the field’s developments since the Myriad decision on patentability of genetic sequences with great interest. One very interesting and very important question is whether the ability to patent naturally occurring genetic … Continue reading






Posted in DTC Genetic Testing, genomics, Oncology, personalized medicine | Comments Off on Continuing Fallout from the Decision to Overturn Myriad’s Patents

Circulating Biomarkers Dundee 2014 a Success!

Circulating Biomarkers Dundee 2014 was a great success! The leadership of Ed Quazi and Elisabetta Fineschi of BioteXcel Ltd. made for a very productive two-day conference with many key leaders in the field from across the UK.  Participants agreed that … Continue reading






Posted in genomics, Oncology, personalized medicine, Uncategorized | Tagged , , , , | Comments Off on Circulating Biomarkers Dundee 2014 a Success!

Was the FDA Right to Shut Down 23andMe’s Marketing?

My opinion: the FDA was right to act in November by asking 23andMe to stop marketing  its personal genome service.  Now, don’t get me wrong, I have been rooting for 23andMe to succeed at what they are doing in the … Continue reading






Posted in DTC Genetic Testing, genomics, personalized medicine | Tagged , , , , , , | Comments Off on Was the FDA Right to Shut Down 23andMe’s Marketing?

FDA Tells 23andMe to Stop Marketing: Death Knell for DTC Genomics 1.0?

The FDA on Friday published a letter  addressed to 23andMe’s CEO, Anne Wojcicki, telling the company to cease marketing it’s Saliva Collection Kit and Personal Genome Service (PGS). In the letter, Alberto Gutierrez, Director of the Office of In vitro … Continue reading






Posted in DTC Genetic Testing, genomics, personalized medicine, Uncategorized | Tagged , , , , , | Comments Off on FDA Tells 23andMe to Stop Marketing: Death Knell for DTC Genomics 1.0?

Gene Patents No More

As most of you know at this point, on Jun 13, 2013 the Supreme Court of the United States ruled essentially that native DNA sequences are not patentable subject matter.  The question ended up with the Supreme Court precisely because … Continue reading






Posted in genomics, personalized medicine | Tagged , , , , , | Comments Off on Gene Patents No More

DTC Genomics: Opportunity Lost?

Once I warmed up to the idea of startup companies offering to sequence the DNA of anyone capable of ordering from Amazon.com, I began to look forward to what might come of this nascent industry. Enabling individuals to have their … Continue reading






Posted in DTC Genetic Testing, genomics, personalized medicine | Tagged , , , , , | Comments Off on DTC Genomics: Opportunity Lost?

Time to Rethink Cancer Therapy?

In an earlier post, I wondered a bit about the ultimately causes of cancer.  For the last several decades cancer has been labeled as a genetic disease, an idea which we have chased with great fervor.  Yet, It feels to … Continue reading






Posted in genomics, Oncology, personalized medicine | Tagged , , , , | Comments Off on Time to Rethink Cancer Therapy?

DTC Genomics Update

I have fallen a bit behind in posts about the DTC genomics field.  One change in my posts to note with respect to this subject, I am going to start using the term “personal genomics” to describe the field, since … Continue reading






Posted in DTC Genetic Testing, genomics, personalized medicine | Tagged , , , , | Comments Off on DTC Genomics Update

DTC Genomics Profitable?

Maybe there is hope that 23andMe, as well as the other DTC genomics companies can make a living in the end: http://www.bio-itworld.com/els/2012/05/29/23andme-announces-first-patent.html Although, it is not clear how useful this particular patent will be.  More detailed discussion here: http://www.genomicslawreport.com/index.php/2012/06/01/patenting-and-personal-genomics-23andme-receives-its-first-patent-and-plenty-of-questions/






Posted in DTC Genetic Testing, genomics, personalized medicine | Tagged , , | Comments Off on DTC Genomics Profitable?